Table 2.
Relationship between PSMC2 expression and tumor characteristics in patients with gallbladder cancer.
| Features | No. of patients | PSMC2 expression | P value | |
|---|---|---|---|---|
| low | high | |||
| All patients | 78 | 41 | 37 | |
| Age (years) | 0.324 | |||
| <65 | 36 | 17 (41.4%) | 19 (51.3%) | |
| ≥65 | 41 | 24 (58.5%) | 17 (45.9%) | |
| Gender | 0.965 | |||
| Male | 23 | 12 (29.2%) | 11 (29.7%) | |
| Female | 55 | 29 (70.8%) | 26 (70.3%) | |
| Grade | < 0.001 | |||
| I | 3 | 3 (7.3%) | 0 (0%) | |
| II | 30 | 26 (63.4%) | 4 (10.8%) | |
| III | 45 | 12 (29.3%) | 33 (89.2%) | |
| T Infiltrate | 0.088 | |||
| T1 | 5 | 4 (9.8%) | 1 (2.7%) | |
| T2 | 23 | 14 (34.1%) | 9 (24.3%) | |
| T3 | 30 | 15 (36.6%) | 15 (40.5%) | |
| T4 | 2 | 0 (0%) | 2 (5.4%) | |
| lymphatic metastasis (N) | 0.675 | |||
| N0 | 45 | 24 (58.5%) | 21 (56.8%) | |
| N1 | 7 | 5 (12.2%) | 2 (5.4%) | |
| N2 | 6 | 3 (7.3%) | 3 (8.1%) | |
| AJCC stage | 0.345 | |||
| 1 | 4 | 3 (7.3%) | 1 (2.7%) | |
| 2 | 13 | 7 (17.1%) | 6 (16.2%) | |
| 3 | 18 | 11 (26.8%) | 7 (18.9%) | |
| 4 | 16 | 7 (17.1%) | 9 (24.3%) | |
| Tumor size | 0.912 | |||
| <4.5 cm | 38 | 20 (48.8%) | 18 (48.6%) | |
| ≥4.5 cm | 37 | 19 (46.3%) | 18 (48.6%) | |
| Lymph node positive | 0.603 | |||
| =0 | 45 | 24 (58.5%) | 21 (56.7%) | |
| å 0 | 13 | 8 (19.5%) | 5 (13.5%) | |
| Metastasize (M) | 0.863 | |||
| M0 | 68 | 36 (87.8%) | 32 (86.5%) | |
| M1 | 10 | 5 (12.2%) | 5 (13.5%) | |